Biomarker

Home
Podcast
Archive
Leaderboard
About
Novartis: Jennifer Brogdon
"There is no script or playbook for this scenario—but we felt that we were mapping a new landscape in medicine."
 • 
Dylan Neel

June 2024

Lab Meeting: Maria Grazia Roncarolo
"Tr1 cells have the potential to not only provide symptom relief, but also reset the immune system to provide cures.”
 • 
Dylan Neel
 and 
Tito Adhikary

April 2024

Radiopharm Renaissance
Case studies, market dynamics and technical hurdles for radioligand therapies
 • 
Dylan Neel
, 
Joseph Mekhael
, and 
Dennis Gong
24 Biotech Investors in 2024
Rising stars in biotech investing and creation discuss how they got started, lessons learned and tips to break into the industry.
 • 
Dylan Neel
 and 
Shreya Mantri

March 2024

Lab Meeting: Mike Rosenblatt
“The biggest breakthroughs are those that wipe away disease.”
 • 
Dylan Neel

February 2024

SR One: Simeon George
“You have to feel fired up about what you're doing.”
 • 
Dylan Neel
 and 
Shreya Mantri
1

January 2024

F-Prime: Alex Pasteur, PhD
On biotech investing and the radiopharmaceutical space
 • 
Dylan Neel
 and 
Joseph Mekhael
BCLS: Adam Koppel
“The last 20 years has been one of the best times for basic science discovery.”
 • 
Dylan Neel

December 2023

SCAN: Sachin Jain
“Just dive in and try to solve problems.”
 • 
Dylan Neel
1
Immunology Cheat Sheet
A guide to the basic biology, clinical development and upcoming readouts in I&I (2023-2024)
 • 
Dylan Neel
 and 
Aniqa Tasnim
6

November 2023

RA Capital: Rajeev Shah
"The ideal investors find a balance."
 • 
Dylan Neel
 and 
Kunal

October 2023

Lab Meeting: Jim Collins
"Can we build something from the bottom up? Can we put circuits together with genes?"
 • 
Dylan Neel
 and 
Kirti Nath
1
© 2024 Dylan Neel
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture